Clinical Trials on Rotavirus Infections

Total 56938 results

GlaxoSmithKline

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Rotavirus Infection | Rotavirus Vaccines

United States
Limited Liability Company Pharm Aid

Completed

Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

Rotavirus Infection

Russian Federation
Cancer Institute and Hospital, Chinese Academy...
Henan Provincal Center for Disease Control and Prevention

Unknown

Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection

Rotavirus Infection

China
PATH

Completed

A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine

Rotavirus Infection

United States
Limited Liability Company Pharm Aid

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Rotavirus Infections | Rotavirus Vaccines

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

Rotavirus Infection

United States
Romark Laboratories L.C.

Completed

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Rotavirus Infection | Viral Gastroenteritis Due to Rotavirus

Egypt
Bharat Biotech International Limited

Recruiting

The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants (Rota5DCHILE)

Rotavirus Infection of Children

Chile
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

HIV Infection | Rotavirus Infection

Botswana, Zimbabwe, Zambia, Tanzania
University of Vermont
International Centre for Diarrhoeal Disease Research, Bangladesh; Thrasher... and other collaborators

Completed

The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

Rotavirus Infection | Vaccine Response Impaired | Vaccine Virus Shedding

Bangladesh
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
GlaxoSmithKline

Completed

Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants

Infections, Rotavirus | Rotavirus Vaccines

Japan
GlaxoSmithKline

Completed

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

Infections, Rotavirus | Rotavirus Vaccines

Philippines
University of Tartu

Unknown

The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines (ERVS)

Rotavirus Infection

Estonia
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

Infections, Rotavirus | Rotavirus Vaccines

Korea, Republic of
Centro Pediatrico Albina de Patino
Instituto de Nutrición y Tecnología de los Alimentos

Completed

Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children

Diarrhea | Rotavirus Infection

Bolivia
GlaxoSmithKline

Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Infections, Rotavirus | Rotavirus Vaccines

Philippines
PATH
Bill and Melinda Gates Foundation; SK Bioscience Co., Ltd.

Recruiting

A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

Rotavirus Infection of Children

Zambia
Centro Pediatrico Albina de Patino

Completed

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus

Diarrhea | Rotavirus Infection

Bolivia
GlaxoSmithKline

Completed

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

Infections, Rotavirus | Rotavirus Vaccines

Belgium
GlaxoSmithKline

Completed

Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden

Infections, Rotavirus | Rotavirus Gastroenteritis
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection
GlaxoSmithKline

Completed

Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis

Infections, Rotavirus | Rotavirus Vaccines

Japan
GlaxoSmithKline

Completed

Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Infections, Rotavirus

India
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
GlaxoSmithKline
Analysis Group, Inc.

Completed

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination

Infections, Rotavirus
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

Infections, Rotavirus

Dominican Republic, Honduras, Panama, Mexico, Brazil, Argentina, Colombia, Chile, Finland, Nicaragua, Peru, Venezuela
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Infections, Rotavirus
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Infections, Rotavirus
GlaxoSmithKline

Completed

Study to Evaluate the Safety of Rotarix™ in Chinese Children

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

Infections, Rotavirus

China
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

Infections, Rotavirus

Bangladesh
GlaxoSmithKline

Completed

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

Infections, Rotavirus

South Africa
GlaxoSmithKline

Completed

Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

Infections, Rotavirus
GlaxoSmithKline

Completed

Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium

Infections, Rotavirus
Merck Sharp & Dohme LLC

Completed

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Rotavirus Disease
GlaxoSmithKline

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus

United States, Taiwan, Canada, Hong Kong, Turkey
GlaxoSmithKline

Completed

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Infections, Rotavirus
GlaxoSmithKline

Completed

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

Drug Use Investigation for ROTARIX®

Infections, Rotavirus
GlaxoSmithKline

Completed

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination

Infections, Rotavirus
GlaxoSmithKline

Completed

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

Infections, Rotavirus

South Africa
GlaxoSmithKline

Completed

Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants

Infections, Rotavirus

Korea, Republic of

3

Subscribe